This article is focused on the business case for ponatinib but it does include some
interesting data and charts on its efficacy.
http://seekingalpha....al?source=yahoo
The case for ponatinib
Started by
chriskuo
, Aug 29 2012 06:15 PM
No replies to this topic
1 user(s) are reading this topic
0 members, 1 guests, 0 anonymous users
